Clinical Trials in Detroit

Showing 16301-16320 of 19,719 trials

Opioids in Chronic Kidney Disease Patients Undergoing Hemodialysis

NCT02452437

To measure oxycodone's intradialytic mass transfer rate coefficient and oxycodone's removal rate using an ODE/PDE hemodialysis model. To implement a rational clinical strategy for estimating a patient's post-hemodialysis oxycodone restoration dose using results from an ODE/PDE model of hemodialysis.

Chronic Kidney Disease

Emerio & Lourdes Linares Research and Education Center20 participantsStarted May 2015

Dearborn, Michigan, United States

COMPLETEDPhase 320 miles

Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus

NCT00108004

This open-label, multicenter study is designed to investigate the clinical utility and safety of pramlintide treatment in subjects with type 1 and type 2 diabetes who are failing to achieve the desired level of glycemic control using insulin therapy.

Type 1 Diabetes MellitusType 2 Diabetes Mellitus

AstraZeneca400 participantsStarted Apr 2003

Anaheim, California, United States • Escondido, California, United States • La Jolla, California, United States +45 more locations

Opioids in Chronic Kidney Disease Patients Undergoing Hemodialysis

Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus

Find Trials by Condition in Detroit

Ultraviolet (UVA and UVB) Light Therapy in the Treatment of Inflammatory Skin Conditions

Benefits of Exercise Training in Head and Neck Cancer Patients Undergoing Organ-Preserving Definitive Therapy

A Twelve Month Long Term Safety Study to Evaluate the Safety of Albuterol in a Dry Powder Inhaler With Both Repeated and as Needed Dosing

Comparison of Two Soft Bifocal Contact Lenses

Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study

Sustained Virological Response (SVR) to Antiviral Treatment of Liver Transplant Recipients With Recurrent Hepatitis C

An Open-Label, Multi-Center, Expanded Access Program With Eribulin for the Treatment of Advanced Breast Cancer Refractory

Study To Evaluate 24 Hour Blood Sugar Control (24-hour Mean Weighted Glucose) In Subjects That Are Taking Saxagliptin 5 mg Added Onto Metformin XR 1500 XR mg Compared To Subjects Taking Metformin XR 1500 mg Up-titrated To Metformin XR 2000 mg

Performance of Two Silicone Hydrogel Toric Contact Lenses

Pazopanib in Previously Treated Patients With Metastatic Renal Cell Carcinoma

A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis

Surgical Versus Nonoperative Treatment of Metastatic Epidural Spinal Cord Compression

Evaluation of Non-cytotoxic Suramin as a Chemosensitizer in Non-small Cell Lung Cancer

A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer

SJG-136 in Treating Patients With Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer That Did Not Respond to Previous Treatment With Cisplatin or Carboplatin

A Study of Oral Clofarabine in Adult Patients With Myelodysplastic Syndromes (MDS)

Improving Asthma Outcomes Through Spirometry Distance Learning

Study to Assess the Safety and Efficacy of Benzocaine for Pain Relief in Children Presenting With Acute Otitis Media